Results 181 to 190 of about 32,846 (250)

Emerging role of insulin with incretin therapies for management of type 2 diabetes [PDF]

, 2011
Rupa Ahluwalia, Jiten Vora
core   +1 more source

Liraglutide Modulates Zinc Release and Improves Mitochondrial Function in Insulin-Resistant Senescent Cardiomyocytes. [PDF]

Cardiovasc Toxicol
Hosseinpourshirazi F, Mendes UD, Aksoy ZB, Aydos D, Sözer M, Aljaser L, Gundogdu M, Sık S, Tuncay E, Turan B, Olgar Y.   +10 more
europepmc   +1 more source

Evaluating the Efficacy, Safety, and Practical Considerations of Semaglutide for Weight Loss in Non‐Diabetic Adults: A Narrative Review

Health Science Reports, Volume 9, Issue 4, April 2026.
ABSTRACT Background and Aims The rising global prevalence of obesity has catalyzed the development of potent glucagon‐like peptide‐1 (GLP‐1) receptor agonists. This narrative review evaluates the efficacy, safety, and practical considerations of injectable semaglutide for weight management, specifically in non‐diabetic adults, a population where weight
Ayesha Laraib, Uswa Ahmad, Syeda Iman Laraib, Syeda Wardah Laraib, Masab Ali, Muhammad Husnain Ahmad, Muhammad Hassan   +6 more
wiley   +1 more source

Preventive effect of liraglutide on postoperative delirium in elderly patients undergoing cardiac surgery: protocol for a single-centre, randomised, double-blind, placebo-controlled trial. [PDF]

BMJ Open
Bai S, Wei M, Wu Y, Zhu X, Wang Z, Wang Y, Zhu C, Guan Y, Wang D, Liu W.   +9 more
europepmc   +1 more source

Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP‐1 Receptor Agonists: A Network Meta‐Analysis of Randomized Controlled Trials

Obesity, Volume 34, Issue 4, Page 770-781, April 2026.
ABSTRACT Objective This study compared the efficacy of metabolic/bariatric surgery (MBS) and GLP‐1 receptor agonists (GLP‐1 RAs), including dual GLP‐1/GIP analogues, for weight and metabolic outcomes in adults with obesity. Methods A network meta‐analysis of randomized controlled trials compared MBS or GLP‐1 RAs versus lifestyle intervention in adults ...
Lucas Sabatella, Patricia M. Ortega, Víctor Valentí Azcárate, Fernando Rotellar Sastre, Adriana Uriz Pagola, Ahmed Ahmed, Sanjay Purkayastha, Carlota Tuero Ojanguren, Nuria Blanco Asensio, Manuel F. Landecho   +9 more
wiley   +1 more source

The effect of combining surgical or endoscopic bariatric interventions with anti-obesity medication or probiotics on weight loss: a narrative review. [PDF]

Front Endocrinol (Lausanne)
de Waal JR, Nieuwdorp M, Gerdes VEA.
europepmc   +1 more source

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023

Obesity, Volume 34, Issue 4, Page 952-960, April 2026.
ABSTRACT Objective This study aimed to evaluate the trends in antiobesity medication (AOM) and metabolic and bariatric surgery (MBS) use relative to the 2013 American Medical Association (AMA) declaration of obesity as a chronic disease and semaglutide approval in 2021 in the United States.
Olajide A. Adekunle, Phuc Le, Christopher Boyer, Hamlet Gasoyan, Dev Yash Gupta, Ha T. Tran, Yihua Yue, Michael B. Rothberg   +7 more
wiley   +1 more source

Joint TOS/OMA/OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach

Obesity, Volume 34, Issue 4, Page 851-870, April 2026.
Guidance recommendations by TOS/OMA/OAC for the use of obesity medications to treat obesity and its complications. ABSTRACT Background Obesity affects over 40% of US adults, with severe obesity on the rise. Despite recognition of obesity as a chronic disease, it remains underdiagnosed and undertreated.
Lydia Alexander, Jonathan Q. Purnell, Karlijn Burridge, Marc‐André Cornier, Angela Golden, Deborah Bade Horn, Michelle Look, Joe Nadglowski, Camila Ávila‐Oliver, Francisco Novillo, Ana María Rojas‐Gómez, Brad Hussey, Ximena Ramos Salas   +12 more
wiley   +1 more source

Anatomical evidence links the stomach to the central amygdala, a region responsive to local GLP-1R agonist induced feeding and nausea-like behaviors in male mice. [PDF]

Front Endocrinol (Lausanne)
Yang H, Yu W, Gao Y, Wang J, Xu S.
europepmc   +1 more source

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study

Obesity Science &Practice, Volume 12, Issue 2, April 2026.
ABSTRACT Objective In general practice settings, the weight‐loss effectiveness of glucagon‐like peptide 1 receptor agonists (GLP‐1 RAs) is often lower than in clinical efficacy trials. Little is known about whether this may be due, in part, to clinicians' knowledge about obesity medicine and the nature of clinic visits (e.g., weight‐focused vs. general
Dina H. Griauzde, Cassie D. Turner, Amal Othman, Lauren Oshman, Jonathan Gabison, Patricia K. Arizaca‐Dileo, James Henderson, Deena Beckius, Joyce M. Lee, Shelley Stoll, Kathryn Herrera‐Theut, Caroline R. Richardson, Jeffrey T. Kullgren, Gretchen A. Piatt, Michele Heisler, Andrew Kraftson   +15 more
wiley   +1 more source